THC

263.1900.15%
MM

Meghan M. FitzGerald

Independent Director

Ms. Meghan M. FitzGerald, also known as Meg, is MD and STO of CIBC Bank USA since 1996. She joined the CIBC Bank USA in 1996. She is Founder of Gray Ghost Ventures and also serves as CEO. She serves as Independent Director at Roivant Sciences Ltd. since March 13, 2023. She serves as Director at Quanta Dialysis Technologies Limited since January 10, 2022. She serves as Independent Director at Tenet Healthcare Corp. since May 29, 2018. She serves as Director at Seniorlink, Inc. since August 30, 2016. She serves as Director at Ageless Innovation LLC since March 2025. She is Senior Advisor at Invidia Capital Management LP. She is Senior Advisor at TowerBrook Capital Partners L.P. She serves as Director at Follica, Inc. She is Managing Partner of L1 Health. She is an advisor to Goldman Sachs. She is an Assistant Professor of Strategy and Health Policy at Columbia University. She serves as a Member of The Advisory Board of the Harvard Kennedy School, Women and Public Policy Program since 2011 and as a Member of The Advisory Board of Yale University Biotech since 2000. She served as Senior Advisor at Revelar Capital, which she joined on January 1, 2021. She served as Independent Director of Thimble Point Acquisition Corp. from February 1, 2021. She served as Independent Non-Executive Director of Arix Bioscience plc from July 21, 2017 to April 1, 2019. She served as Independent Director at Concert Pharmaceuticals, Inc. from March 22, 2016 to December 11, 2018. She served as Senior Advisor at PureTech Health plc from July 8, 2016 to April 6, 2017. She served as Executive VP of Health Policy & Strategy at Cardinal Health, Inc. from May 2015 to December 2016. At Cardinal Health, Inc., she also served as President of Specialty Solutions from October 2010 to May 2015. She served as Director of Gelesis Holdings, Inc. from March 2015. She served as Senior Vice President of New Markets International Division and Business Development at Medco Health Solutions, Inc. from March 2008 to July 2010. She served as Chief Business Officer and Vice President at Vion Pharmaceuticals Inc., where she was employed from January 2006 to April 4, 2008. She worked at Pfizer, Inc. from 2001 to early 2006, where she served as Senior Director of Strategic Planning and Business Development for Pfizer Global Pharmaceuticals and as Worldwide Marketing Director of Lifecycle Management. As Worldwide Marketing Director, she led a team responsible for implementing a ten-year lifecycle plan for various pharmaceutical products. She served as Director of Marketing at Sanofi-Synthelabo, Inc. from 1999 to 2001. She served as Director of Marketing at Merck & Co., Inc. from 1997 to 1999. She is Founder of K2 HealthVentures and also served as a Board Member. She served as CEO and Managing Partner at LetterOne Holdings S.A. Ms. FitzGerald is a private equity investor and global healthcare strategist with experience in the US healthcare industry, with a strong emphasis on operations, health policy, and business development. She has worked for many prominent healthcare firms. Her accomplishments include developing several international and high-profile product launch strategies, which helped achieve positioning, pricing, regulatory and commercial milestones. She received a Doctorate in Public Health from New York Medical College, an M.P.H from Columbia University, and a Bachelor's in Nursing from Fairfield University. She also holds a a Master of Science in Nursing.

公司职务